Introduction: Treatment with dasatinib for chronic myeloid leukemia (CML) has been associated with development of pleural effusion, however data regarding its optimal management are limited. We examin
ABL mutations inhibitory activity in BAF3 cellsModels of ABL kinase wt and mutantsAntiproliferation of CHMFL-48 in CML cell lines In vivo anti-tumour efficacy
Introduction Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm marked by the presence of the Philadelphia chromosome and uncontrolled granulocyte production. While autoimmune hemolytic a